Publicaciones en las que colabora con URKO AGUIRRE LARRAKOETXEA (7)

2023

  1. Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease

    United European Gastroenterology Journal, Vol. 11, Núm. 1, pp. 9-18

2020

  1. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease

    United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066

  2. Gastrointestinal infection with Aeromonas: incidence and relationship to inflammatory bowel disease

    Gastroenterologia y Hepatologia, Vol. 43, Núm. 10, pp. 614-619

  3. Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel disease

    Alimentary Pharmacology and Therapeutics, Vol. 51, Núm. 9, pp. 870-879

2019

  1. Granulocyte–monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis

    Scandinavian Journal of Gastroenterology, Vol. 54, Núm. 4, pp. 459-464

2018

  1. Characteristics and Progression of Preclinical Inflammatory Bowel Disease

    Clinical Gastroenterology and Hepatology, Vol. 16, Núm. 9, pp. 1459-1466

2016

  1. Previous exposure to biologics and C-reactive protein are associated with the response to tacrolimus in inflammatory bowel disease

    Revista Espanola de Enfermedades Digestivas, Vol. 108, Núm. 9, pp. 550-557